AbbVie’s Rinvoq gains recommended approval by CHMP - Drug Informics

Post Top Ad

Monday, 27 June 2022

AbbVie’s Rinvoq gains recommended approval by CHMP

CHMP returns positive opinion on Rinvoq for the treatment of adults with active non-radiographic axial spondyloarthritis

from PharmaTimes: News RSS https://ift.tt/AZpVQFh

No comments:

Post a Comment

Post Top Ad